Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab in Primary Hyperparathyroidism

NCT01558115 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01558115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01558115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab in Primary Hyperparathyroidism
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2012
Completion date
October 31, 2014
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary hyperparathyroidism